Company logo

CANO - Cano Health, Inc.

NYSE -> Healthcare -> Medical Care Facilities
Miami, United States
Type: Equity

CANO price evolution
CANO
(in millions $) 30 Oct 2023 30 Jul 2023 1 May 2023 31 Jan 2023
Current assets
Cash
Short term investments
Net receivables $87.5 $107.16 $242.22 $233.82
Inventory
Total current assets $144.7 $166.34 $313.69 $340.75
Long term investments
Property, plant & equipment $243.8 $303.91 $310.79 $309.22
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $1211.9 $1707.32 $1944.38 $1928.93
Current liabilities
Accounts payable $135.9 $124.82 $115.23 $105.73
Deferred revenue
Short long term debt
Total current liabilities $365.9 $336.93 $213.91 $208.44
Long term debt $959 $930 $1016.44 $1001.17
Total noncurrent liabilities
Total debt
Total liabilities $1334 $1560.62 $1663.51 $1676.3
Shareholders' equity
Retained earnings -$715.4 -$454.94 -$314.18 -$286.03
Other shareholder equity
Total shareholder equity
(in millions $) 31 Jan 2023 31 Jan 2022 30 Jan 2021 30 Jan 2020
Current assets
Cash $1.04
Short term investments
Net receivables $233.82 $133.43 $67.35 $49.25
Inventory $1.11 $0.92 $0.65
Total current assets $340.75 $317.24 $1.22 $82.88
Long term investments
Property, plant & equipment $309.22 $217.43 $38.13 $19.15
Goodwill & intangible assets
Total noncurrent assets $690.31 $0.05
Total investments
Total assets $1928.93 $2143.54 $691.53 $0.05
Current liabilities
Accounts payable $105.73 $72.77 $31.37 $12.72
Deferred revenue
Short long term debt
Total current liabilities $208.44 $161.04 $2.18 $0.05
Long term debt $1001.17 $918.78 $459.2 $134.03
Total noncurrent liabilities $684.35
Total debt
Total liabilities $1676.3 $1824.81 $686.53 $0.05
Shareholders' equity
Retained earnings -$286.03 -$78.76 -$28.89 -$0.01
Other shareholder equity -$0.13 -$0.13
Total shareholder equity
(in millions $) 30 Oct 2022 30 Jul 2022 1 May 2022 31 Jan 2022
Revenue
Total revenue $665.03 $689.37
Cost of revenue
Gross Profit
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $696.47 $720.42
Operating income
Income from continuing operations
EBIT
Income tax expense -$1.25 $0.81
Interest expense -$82.17 $17.04
Net income
Net income -$54.23 -$5.33
Income (for common shares)
(in millions $) 31 Jan 2022 30 Jan 2021 30 Jan 2020
Revenue
Total revenue $1609.37
Cost of revenue
Gross Profit
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $1744.56 $5.71
Operating income -$5.71
Income from continuing operations
EBIT
Income tax expense $0.01
Interest expense $31.63
Net income
Net income -$18.02 -$28.88
Income (for common shares)
(in millions $) 30 Oct 2022 30 Jul 2022 1 May 2022 31 Jan 2022
Net income
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$48.15 -$29.27 -$13.46 -$1131.25
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing -$6.76 -$3.88 $0.54 $1389.14
Effect of exchange rate
Change in cash and equivalents -$139.07 -$115.32 -$50.12 $129.36
(in millions $) 31 Jan 2022 30 Jan 2021 30 Jan 2020
Net income -$28.88
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$1.15
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$1131.25 -$690
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing $1389.14 $692.19
Effect of exchange rate
Change in cash and equivalents $129.36 $1.04
Fundamentals
Market cap $1.88M
Enterprise value N/A
Shares outstanding 5.40M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q 26.24%
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio 0.40
Quick ratio N/A